Drug Database
Back to search

United States· US:0143-9670_239c7e32-be35-41ea-b466-2e15d3339398

Cefotetan

A cefotetan product containing cefotetan, registered in United States by Hikma Pharmaceuticals USA Inc..

ATC J01DC05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCefotetanATCJ01DC05REGISTER NO.US:0143-9670_239c7e32…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cefotetanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CEFOTETAN
Manufacturer
Hikma Pharmaceuticals USA Inc.
Country
United States (US)
ATC code
J01DC05
ATC class
Cefotetan
Defined daily dose
4 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0143967010
    10 VIAL in 1 CARTON (0143-9670-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9670-01)
  • ndc11
    0143-9670-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for cefotetan.

Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cefotetan against other medicinesHow interaction checks work

Cefotetan · interactions on record

25 records

  • 25 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01DC05

Cefotetan, as other registers publish it.

All cefotetan products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cbc2517d-1f1b-4790-9677-3965b35e7a6c
GET /v1/drugs/cbc2517d-1f1b-4790-9677-3965b35e7a6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "CEFOTETAN",
  "productndc": "0143-9670",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/1",
  "application_number": "ANDA091031",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about cefotetan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console